Skip to main content

Coherus BioSciences to Report Third Quarter 2022 Financial Results on November 8th, 2022

REDWOOD CITY, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its third quarter 2022 financial results will be released after market close on Tuesday, November 8th, 2022. Starting at 5:00 p.m. Eastern Time on November 8, 2022, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update. The press release with the third quarter 2022 financial results and related materials will be available at https://investors.coherus.com prior to the start of the conference call.

A replay of the webcast will be available on http://investors.coherus.com following the conclusion of the live conference call.

Conference Call Information
When: Tuesday, November 8th, 2022, starting at 5:00 p.m. Eastern Time
To access the conference call, please pre-register through the following link to receive dial-in information and personal PIN to access the live call: https://register.vevent.com/register/BI79684ca1b45c46df988c8f9aac6f09af

Webcast: https://investors.coherus.com/upcoming-events

Please dial-in 15 minutes early to ensure a timely connection to the call.

Coherus Contact Information:
Marek Ciszewski, SVP Investor Relations
Coherus Biosciences, Inc.
IR@coherus.com



Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.53
-0.26 (-0.13%)
AAPL  262.95
-1.40 (-0.53%)
AMD  201.47
+1.35 (0.67%)
BAC  52.60
-0.76 (-1.43%)
GOOG  304.46
+0.52 (0.17%)
META  645.22
+2.00 (0.31%)
MSFT  399.13
-0.47 (-0.12%)
NVDA  186.66
-1.31 (-0.70%)
ORCL  157.91
+1.74 (1.11%)
TSLA  414.01
+2.69 (0.66%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.